Patrick Y. Wen
Active 1990–2026
- Also published as
- Patrick Y Wen
- 441
- Papers
- 81,000
- Citations
- 148
- h-index
- 418
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine63%
- Biochemistry, Genetics and Molecular Biology22.2%
- Immunology and Microbiology5.3%
- Neuroscience3.2%
- Engineering1.9%
- Materials Science1.5%
- Other2.9%
Topics
- Glioma Diagnosis and Treatment13.3%
- Brain Metastases and Treatment5.4%
- Radiomics and Machine Learning in Medical Imaging2.6%
- Cancer Immunotherapy and Biomarkers2.6%
- Meningioma and schwannoma management2.4%
- Cancer, Hypoxia, and Metabolism2.1%
- Other71.6%
Coauthors
- Timothy F. Cloughesy90
- David A. Reardon79
- Martin J. van den Bent74
- Susan M. Chang67
- Keith L. Ligon58
- Eudocia Q. Lee56
- Michael Weller56
- David Schiff53
- Minesh P. Mehta48
- Raymond Y. Huang45
- Tracy T. Batchelor45
- Benjamin M. Ellingson43
- Jan Drappatz41
- Evanthia Galanis38
- Michael A. Vogelbaum38
- Mark R. Gilbert36
- Wenya Linda Bi36
- Burt Nabors35
- Brian M. Alexander34
- Ingo K. Mellinghoff33
- Manmeet S. Ahluwalia32
- Michael D. Prados32
- Andrew D. Norden29
- Elizabeth R. Gerstner29
All papers
- Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Authors: Patrick Y. Wen, Michael Weller, Eudocia Q. Lee, Brian M. Alexander, Jill S. Barnholtz‐Sloan, Floris P Barthel, Tracy T. Batchelor, Ranjit S. Bindra, Susan M. Chang, E. Antonio Chiocca, Timothy F. Cloughesy, John DeGroot, Evanthia Galanis, Mark R. Gilbert, Monika E. Hegi, Craig Horbinski, Raymond Y. Huang, Andrew B. Lassman, Émilie Le Rhun, Michael Lim, Minesh P. Mehta, Ingo K. Mellinghoff, Giuseppe Minniti, David A. Nathanson, Michael Platten, Matthias Preusser, Patrick Roth, Marc Sanson, David Schiff, Susan Short, Martin Taphoorn, Joerg-Christian Tonn, Jonathan Tsang, Roel G.W. Verhaak, Andreas von Deimling, Wolfgang Wick, Gelareh Zadeh, David A. Reardon, Kenneth Aldape, Martin J. van den Bent - Neuro-Oncology 2020 cited by 1,137
- Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Authors: Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal, Mehdi Touat, Katherine B. Peters, Jennifer Clarke, Joe Mendez, Shlomit Yust‐Katz, Liam Welsh, Warren Mason, François Ducray, Yoshie Umemura, Burt Nabors, Matthias Holdhoff, Andreas F. Hottinger, Yoshiki Arakawa, Juan Manuel Sepúlveda-Sánchez, Wolfgang Wick, Riccardo Soffietti, James Perry, Pierre Giglio, Macarena de la Fuente, Elizabeth A. Maher, Steven Schoenfeld, Dan Zhao, Shuchi S. Pandya, Lori Steelman, Islam Hassan, Patrick Y. Wen, Timothy F. Cloughesy - New England Journal of Medicine 2023 cited by 719
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Authors: Derin B. Keskin, Annabelle Anandappa, Jing Sun, Itay Tirosh, Nathan D. Mathewson, Shuqiang Li, Giacomo Oliveira, Anita Giobbie‐Hurder, Kristen D. Felt, Evisa Gjini, Sachet A. Shukla, Zhuting Hu, Letitia Li, Phuong M. Le, Rosa Lundbye Allesøe, Alyssa Richman, Monika S. Kowalczyk, Sara Abdelrahman, Jack Geduldig, Sarah Charbonneau, Kristine Pelton, J. Bryan Iorgulescu, Liudmila Elagina, Wandi Zhang, Oriol Olive, Christine McCluskey, Lars Rønn Olsen, Jonathan Stevens, William J. Lane, Andres Μ. Salazar, Heather Daley, Patrick Y. Wen, E. Antonio Chiocca, Maegan Harden, Niall J. Lennon, Stacey Gabriel, Gad Getz, Eric S. Lander, Aviv Regev, Jerome Ritz, Donna Neuberg, Scott J. Rodig, Keith L. Ligon, Mario L. Suvà, Kai W. Wucherpfennig, Nir Hacohen, Edward F. Fritsch, Kenneth J. Livak, Patrick A. Ott, Catherine J. Wu, David A. Reardon - Nature 2018 cited by 1,464
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Authors: Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Willy Hugo, Alex Lee, Tom B. Davidson, Anthony Wang, Benjamin M. Ellingson, Julie Rytlewski, Catherine Sanders, Eric S. Kawaguchi, Lin Du, Gang Li, William H. Yong, Sarah Gaffey, Adam L. Cohen, Ingo K. Mellinghoff, Eudocia Q. Lee, David A. Reardon, Barbara O’Brien, Nicholas Butowski, Phioanh L. Nghiemphu, Jennifer Clarke, Isabel Arrillaga‐Romany, Howard Colman, Thomas Kaley, John de Groot, Linda M. Liau, Patrick Y. Wen, Robert M. Prins - Nature Medicine 2019 cited by 1,387
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Authors: Patrick Y. Wen, David R. Macdonald, David A. Reardon, Timothy F. Cloughesy, A. Gregory Sorensen, Evanthia Galanis, John DeGroot, Wolfgang Wick, Mark R. Gilbert, Andrew B. Lassman, Christina Tsien, Tom Mikkelsen, Eric T. Wong, Marc C. Chamberlain, Roger Stupp, Kathleen R. Lamborn, Michael A. Vogelbaum, Martin J. van den Bent, Susan M. Chang - Journal of Clinical Oncology 2010 cited by 3,829
- Glioma
Authors: Michael Weller, Wolfgang Wick, Ken Aldape, Michael Brada, Mitchel S. Berger, Stefan M. Pfister, Ryo Nishikawa, Mark Rosenthal, Patrick Y. Wen, Roger Stupp, Guido Reifenberger - Nature Reviews Disease Primers 2015 cited by 1,149
- RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
Authors: Patrick Y. Wen, Martin J. van den Bent, Gilbert Youssef, Timothy F. Cloughesy, Benjamin M. Ellingson, Michael Weller, Evanthia Galanis, Daniel P. Barboriak, John de Groot, Mark R. Gilbert, Raymond Y. Huang, Andrew B. Lassman, Minesh P. Mehta, Annette M. Molinaro, Matthias Preusser, Rifaquat Rahman, Lalitha Shankar, Roger Stupp, Javier Villanueva-Meyer, Wolfgang Wick, David R. Macdonald, David A. Reardon, Michael A. Vogelbaum, Susan M. Chang - Journal of Clinical Oncology 2023 cited by 462
- Malignant Gliomas in Adults
Authors: Patrick Y. Wen, Santosh Kesari - New England Journal of Medicine 2008 cited by 4,241
- Clinical trial links oncolytic immunoactivation to survival in glioblastoma
Authors: Alexander Ling, Isaac H. Solomon, Ana Montalvo Landivar, Hiroshi Nakashima, Jared K. Woods, Andres Santos, Nafisa Masud, Geoffrey Fell, Xiaokui Mo, Ayse Selen Yilmaz, J. K. Grant, Abigail Zhang, Joshua D. Bernstock, Erickson Torio, Hirotaka Ito, Junfeng Liu, Naoyuki Shono, Michal O. Nowicki, Daniel Triggs, Patrick Halloran, Raziye Piranlioglu, Himanshu Soni, Brittany M. Stopa, Wenya Linda Bi, Pierpaolo Peruzzi, Ethan Chen, Seth Malinowski, Michael C. Prabhu, Yu Zeng, Anne E. Carlisle, Scott J. Rodig, Patrick Y. Wen, Eudocia Q. Lee, Lakshmi Nayak, Ugonma Chukwueke, L. Nicolas Gonzalez Castro, Sydney Dumont, Tracy T. Batchelor, Kara A. Kittelberger, Ekaterina Tikhonova, Natalia Miheecheva, D Tabakov, Nara Shin, Alisa M. Gorbacheva, Artemy Shumskiy, Felix Frenkel, Estuardo Aguilar-Córdova, Laura K. Aguilar, David Krisky, James Wechuck, Andrea G. Manzanera, Christopher Matheny, Paul P. Tak, Francesca Barone, Daniel Kovarsky, Itay Tirosh, Mario L. Suvà, Kai W. Wucherpfennig, Keith L. Ligon, David A. Reardon, E. Antonio Chiocca - Nature 2023 cited by 256
- Mechanisms and therapeutic implications of hypermutation in gliomas
Authors: Mehdi Touat, Yvonne Y. Li, Adam N. Boynton, Liam F. Spurr, J. Bryan Iorgulescu, Craig L. Bohrson, Isidro Cortés‐Ciriano, Cristina Birzu, Jack Geduldig, Kristine Pelton, Mary Jane Lim-Fat, Sangita Pal, Rubén Ferrer-Luna, Shakti Ramkissoon, Frank Dubois, Charlotte Bellamy, Naomi Currimjee, Juliana Bonardi, Kenin Qian, Patricia Ho, Seth Malinowski, Léon Taquet, Robert E. Jones, Aniket Shetty, Kin-Hoe Chow, Radwa Sharaf, Dean C. Pavlick, Lee A. Albacker, Nadia Younan, Capucine Baldini, Maïté Verreault, Marine Giry, Erell Guillerm, Samy Ammari, Frédéric Beuvon, Karima Mokhtari, Agustí Alentorn, Caroline Dehais, Caroline Houillier, Florence Laigle–Donadey, Dimitri Psimaras, Eudocia Q. Lee, Lakshmi Nayak, J Ricardo McFaline-Figueroa, Alexandre Carpentier, Philippe Cornu, Laurent Capelle, Bertrand Mathon, Jill S. Barnholtz‐Sloan, Arnab Chakravarti, Wenya Linda Bi, E. Antonio Chiocca, Katie Fehnel, Sanda Alexandrescu, N. Susan, Daphne A. Haas‐Kogan, Tracy T. Batchelor, Garrett M. Frampton, Brian M. Alexander, Raymond Y. Huang, Azra H. Ligon, Florence Coulet, Jean‐Yves Delattre, Khê Hoang‐Xuan, David M. Meredith, Sandro Santagata, Alex Duval, Marc Sanson, Andrew D. Cherniack, Patrick Y. Wen, David A. Reardon, Aurélien Marabelle, Peter J. Park, Ahmed Idbaïh, Rameen Beroukhim, Pratiti Bandopadhayay, Franck Bielle, Keith L. Ligon - Nature 2020 cited by 720
- Response assessment criteria for brain metastases: proposal from the RANO group
Authors: Nancy U. Lin, Eudocia Q. Lee, Hidefumi Aoyama, Igor J. Barani, Daniel P. Barboriak, Brigitta G. Baumert, Martin Bendszus, Paul D. Brown, D. Ross Camidge, Susan M. Chang, Janet Dancey, Elisabeth G.E. de Vries, Laurie E. Gaspar, Gordon J. Harris, F. Stephen Hodi, Steven N. Kalkanis, Mark E. Linskey, David Macdonald, Kim Margolin, Minesh P. Mehta, David Schiff, Riccardo Soffietti, John H. Suh, Martin J. van den Bent, Michael A. Vogelbaum, Patrick Y. Wen - The Lancet Oncology 2015 cited by 1,088
- Glioma
Authors: Michael Weller, Patrick Y. Wen, Susan M. Chang, Linda Dirven, Michael Lim, Michelle Monje, Guido Reifenberger - Nature Reviews Disease Primers 2024 cited by 492
- Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
Authors: Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg, Anas Gazzah, Ulrik Lassen, Alexander Stein, Patrick Y. Wen, Sascha Dietrich, Maja J.A. de Jonge, Jean‐Yves Blay, Antoîne Italiano, Kan Yonemori, Daniel C. Cho, Filip De Vos, Philippe Moreau, Elena Élez, Jan H.M. Schellens, Christoph Zielinski, Suman Redhu, Aislyn Boran, Vanessa Q. Passos, Palanichamy Ilankumaran, Yung‐Jue Bang - Nature Medicine 2023 cited by 298
- Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Authors: Nicholas Butowski, Howard Colman, John de Groot, Antonio Omuro, Lakshmi Nayak, Patrick Y. Wen, Timothy F. Cloughesy, Adhirai Marimuthu, Sam Haidar, Arie Perry, Jason T. Huse, Joanna J. Phillips, Brian L. West, K. B. Nolop, Henry H. Hsu, Keith L. Ligon, Annette M. Molinaro, Michael D. Prados - Neuro-Oncology 2015 cited by 580
- Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
Authors: Daniel Cagney, Allison Martin, Paul J. Catalano, Amanda J. Redig, Nancy U. Lin, Eudocia Q. Lee, Patrick Y. Wen, Ian F. Dunn, Wenya Linda Bi, Stephanie E. Weiss, Daphne A. Haas‐Kogan, Brian M. Alexander, Ayal A. Aizer - Neuro-Oncology 2017 cited by 838
- Epidemiology of Brain Metastases
Authors: Lakshmi Nayak, Eudocia Q. Lee, Patrick Y. Wen - Current Oncology Reports 2011 cited by 1,372
- Molecular targeted therapy of glioblastoma
Authors: Émilie Le Rhun, Matthias Preusser, Patrick Roth, David A. Reardon, Martin J. van den Bent, Patrick Y. Wen, Guido Reifenberger, Michael Weller - Cancer Treatment Reviews 2019 cited by 724
- Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
Authors: Vivek Subbiah, Ulrik Lassen, Élena Elez, Antoîne Italiano, Giuseppe Curigliano, Milind Javle, Filippo de Braud, Gerald W. Prager, Richard Greil, Alexander Stein, Angelica Fasolo, Jan H.M. Schellens, Patrick Y. Wen, Kert Viele, Aislyn Boran, Eduard Gasal, Paul Burgess, Palanichamy Ilankumaran, Zev A. Wainberg - The Lancet Oncology 2020 cited by 518
- Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
Authors: Julie J. Miller, L. Nicolas Gonzalez Castro, Samuel K. McBrayer, Michael Weller, Timothy F. Cloughesy, Jana Portnow, Ovidiu C. Andronesi, Jill S. Barnholtz‐Sloan, Brigitta G. Baumert, Mitchel S. Berger, Wenya Linda Bi, Ranjit S. Bindra, Daniel P. Cahill, Susan M. Chang, J Costello, Craig Horbinski, Raymond Y. Huang, Robert B. Jenkins, Keith L. Ligon, Ingo K. Mellinghoff, Burt Nabors, Michael Platten, David A. Reardon, Diana D. Shi, David Schiff, Wolfgang Wick, Hai Yan, Andreas von Deimling, Martin J. van den Bent, William G. Kaelin, Patrick Y. Wen - Neuro-Oncology 2022 cited by 237
- Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
Authors: Patrick Y Wen, Alexander Stein, Martin van den Bent, Jacques De Greve, Antje Wick, Filip Y F L de Vos, Nikolas von Bubnoff, Myra E van Linde, Albert Lai, Gerald W Prager, Mario Campone, Angelica Fasolo, Jose A Lopez-Martin, Tae Min Kim, Warren P Mason, Ralf-Dieter Hofheinz, Jean-Yves Blay, Daniel C Cho, Anas Gazzah, Damien Pouessel, Jeffrey Yachnin, Aislyn Boran, Paul Burgess, Palanichamy Ilankumaran, Eduard Gasal, Vivek Subbiah - The Lancet Oncology 2021 cited by 353
- Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer
Authors: Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg, Y. Choi, Jan H.M. Schellens, Jean Charles Soria, Patrick Y. Wen, Christoph Zielinski, Maria E. Cabanillas, Gladys Urbanowitz, Bijoyesh Mookerjee, Dazhe Wang, Fatima Rangwala, Bhumsuk Keam - Journal of Clinical Oncology 2017 cited by 885
- Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Authors: Lakshmi Nayak, Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot, Leia Nghiemphu, Thomas Kaley, Howard Colman, Christine McCluskey, Sarah Gaffey, Timothy R. Smith, David J. Coté, Mariano Severgnini, Jennifer H. Yearley, Qing Zhao, Wendy M. Blumenschein, Dan G. Duda, Alona Muzikansky, Rakesh K. Jain, Patrick Y. Wen, David A. Reardon - Clinical Cancer Research 2020 cited by 257
- Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours
Authors: Craig Horbinski, Tamar Berger, Roger J. Packer, Patrick Y. Wen - Nature Reviews Neurology 2022 cited by 298
- Epidemiology of brain metastases and leptomeningeal disease
Authors: Nayan Lamba, Patrick Y. Wen, Ayal A. Aizer - Neuro-Oncology 2021 cited by 384
